AL
COR icon

Aspiriant LLC’s Cencora COR Stock Holding History

Aspiriant LLC’s Portfolio COR Stock Details COR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+729
New +$210K 0.01% 384
2026
Q1 		– Sell
-603
Closed -$204K – 341
2025
Q4 		$204K Buy
+603
New +$206K 0.01% 315
2024
Q2 		– Sell
-1,088
Closed -$264K – 294
2024
Q1 		$264K Hold
1,088
– – 0.01% 272
2023
Q4 		$223K Buy
+1,088
New +$212K 0.01% 278

Other funds holding COR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aspiriant LLC's COR Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Cencora (COR) in Q2 2026: 729 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #384 among its holdings. This is a return to the name: Aspiriant LLC previously reported a position in COR as recently as Q4 2025.

Aspiriant LLC first reported a position in COR in Q4 2023 and has held it in 4 quarters since. The position peaked at $264K in Q1 2024. 1,345 funds tracked by Wall St. Rank hold COR as of Q2 2026.

  • Aspiriant LLC held 729 shares of Cencora worth $206K as of Q2 2026.
  • Cencora was a new Aspiriant LLC position in Q2 2026.
  • Cencora made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #384 holding.
  • Aspiriant LLC first reported a position in Cencora in Q4 2023 and has held it in 4 quarters since.
  • Aspiriant LLC's Cencora position peaked at $264K in Q1 2024.
  • 1,345 funds tracked by Wall St. Rank held Cencora as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.